- Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances
- Browse: 74 Download: 305 Issue Date: 2026-07-24
- Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction
- Browse: 72 Download: 219 Issue Date: 2026-07-24
- Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
- Browse: 70 Download: 224 Issue Date: 2026-07-24
- Computed tomography-based correction of the body mass index improves malnutrition detection in patients with cirrhosis and ascites
- Browse: 69 Download: 239 Issue Date: 2026-07-24
- Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
- Browse: 68 Download: 185 Issue Date: 2026-07-24
- Tyrosine kinase inhibitors after progression on atezolizumab-bevacizumab in advanced hepatocellular carcinoma: A systematic review and meta-analysis
- Browse: 135 Download: 424 Issue Date: 2026-06-26
- Methionine depletion inhibits hepatocellular carcinoma by inducing ferroptosis and suppressing epithelial-mesenchymal transition through the ARNT2/UBE2Z pathway
- Browse: 117 Download: 304 Issue Date: 2026-06-26
- LECT2/Tie1/Src signaling regulates the oxidative stress response in endothelial cells and liver ischemia-reperfusion injury
- Browse: 107 Download: 393 Issue Date: 2026-06-26
- Emerging treatment options for metabolic dysfunction-associated steatotic liver disease and its related liver diseases
- Browse: 135 Download: 243 Issue Date: 2026-06-26
- Metabolic links between metabolic dysfunction-associated steatotic liver disease and primary biliary cholangitis
- Browse: 104 Download: 319 Issue Date: 2026-06-26
- Genetic polymorphism of IFI16 and AIM2 among Pakistani hepatitis C virus-induced fibrosis patients
- Browse: 85 Download: 300 Issue Date: 2026-05-26
- Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study
- Browse: 72 Download: 295 Issue Date: 2026-05-26
- Anti-obesity medications, the new frontiers, in metabolic dysfunction-associated fatty liver disease: Efficacy, limitations, and future directions
- Browse: 66 Download: 230 Issue Date: 2026-05-26
- Congenital porto-sinusoidal vascular disorder-induced portal hypertension: A comprehensive review based on a classic clinical case
- Browse: 76 Download: 234 Issue Date: 2026-05-26
- Liver injury after COVID-19 vaccination: Current status and future perspectives
- Browse: 76 Download: 240 Issue Date: 2026-05-26
- Diagnostic accuracy of blood-based non-invasive tests for prediction of varices in pediatric portal-hypertension: A systematic review and meta-analysis
- Browse: 130 Download: 335 Issue Date: 2026-04-21
- Correlation between non-alcoholic fatty liver disease and erectile dysfunction: A systematic narrative review
- Browse: 144 Download: 259 Issue Date: 2026-04-21
- Novel nomogram for differential diagnosis of UGT1A1 gene mutation-associated unconjugated hyperbilirubinemia with hemolytic diseases
- Browse: 150 Download: 318 Issue Date: 2026-04-21
- Metabolic dysfunction-associated steatotic liver disease mediates the relationship between helicobacter pylori infection and colorectal adenoma risk
- Browse: 128 Download: 281 Issue Date: 2026-04-21
- Monocyte reprogramming and trained immunity: Linking metabolism to inflammation in non-alcoholic fatty liver disease
- Browse: 108 Download: 217 Issue Date: 2026-04-21